Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma. - Wikidata - wikimedia - TriplyDB

Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma.

Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma.

http://www.wikidata.org/entity/Q40275006

about

A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma A novel biomarker TERTmRNA is applicable for early detection of hepatoma.HCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinoma Expansion of interferon-gamma-producing multifunctional CD4+ T-cells and dysfunctional CD8+ T-cells by glypican-3 peptide library in hepatocellular carcinoma patients.Hepatocellular carcinoma: novel molecular targets in carcinogenesis for future therapies Co-culture of primary human tumor hepatocytes from patients with hepatocellular carcinoma with autologous peripheral blood mononuclear cells: study of their in vitro immunological interactions.Interferon alpha on expression of hTERT mRNA in peripheral blood mononuclear cells of patients with chronic hepatitis B.Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma.A functional insertion/deletion polymorphism in the proximal promoter of CD3G is associated with susceptibility for hepatocellular carcinoma in Chinese population.Correlation between the expression of hTERT gene and the clinicopathological characteristics of hepatocellular carcinoma Telomerase-based immunotherapy of cancer.Telomerase immunity from bench to bedside: round one.Prospects and challenges of building a cancer vaccine targeting telomerase Inhibition of hepatocellular carcinoma growth by adenovirus-mediated expression of human telomerase reverse transcriptase COOH-27 terminal polypeptide in mice Cellular Immune Responses for Squamous Cell Carcinoma Antigen Recognized by T Cells 3 in Patients with Hepatocellular Carcinoma.Adaptive immunity in hepatocellular carcinoma: prognostic and therapeutic implications.Current status of GV1001 and other telomerase vaccination strategies in the treatment of cancer.Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy.Spontaneous and therapeutic immune responses in hepatocellular carcinoma: implications for current and future immunotherapies.A new hope in immunotherapy for malignant gliomas: adoptive T cell transfer therapy.Immunotherapy in hepatocellular carcinoma: Primed to make a difference?Identification of two new HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from colorectal carcinoma-associated antigen PLAC1/CP1.Detection of telomerase reverse transcriptase mRNA in peripheral blood mononuclear cells of patients with liver failure.Skin delivery of short hairpin RNA of indoleamine 2,3 dioxygenase induces antitumor immunity against orthotopic and metastatic liver cancer.The immune system in hepatocellular carcinoma and potential new immunotherapeutic strategies.Myeloid-derived suppressor cells correlate with patient outcomes in hepatic arterial infusion chemotherapy for hepatocellular carcinoma.Tumor-associated antigens for specific immunotherapy of prostate cancer A new cloning and expression system yields and validates TCRs from blood lymphocytes of patients with cancer within 10 days.P53, hTERT, WT-1, and VEGFR2 are the most suitable targets for cancer vaccine therapy in HLA-A24 positive pancreatic adenocarcinoma.Enhancement of tumor-associated antigen-specific T cell responses by radiofrequency ablation of hepatocellular carcinoma.Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma.Antiproliferative effect of the isoquinoline alkaloid papaverine in hepatocarcinoma HepG-2 cells--inhibition of telomerase and induction of senescence.Immune responses of human T lymphocytes to novel hepatitis B virus-derived peptides.

P2860

Q33579629-78290A4E-B54C-46D6-A2B3-B5343E3195DD Q33581156-C0A8711E-FD95-4DA3-BB4F-8359F7B74B53 Q33779140-8A7FD2AD-8852-4641-81C0-78780E54852F Q33850655-BC044652-7963-436B-8315-0CD7C140E71E Q33895113-3CE83138-88F3-4597-831D-110985609793 Q34554049-B7F52F53-8B17-4E3B-8F7D-C800769E5CE2 Q35008784-2431A00C-7C6D-4949-8AC8-A54694F5E569 Q35091441-0511704E-42A1-4C11-AE8D-7EFE53FF468F Q35894880-BFC87607-FE0F-40AB-A4DF-9151CA02D40B Q36194154-FDA65C6D-E6BC-4D92-988D-B965A15E5572 Q36502912-5AA76675-17F1-481A-99C2-C7D20267CCFC Q36600251-BB6DF289-4667-4557-A83B-DD1D3C1D4BBB Q36745749-4EA59B5E-0786-4B28-A8B8-A068B618AF5B Q36918394-420D7FFA-FCC0-4168-89C6-5963DC6BC124 Q37211843-D6788137-512E-4637-B0A5-B497E6C5E60A Q37600523-AD9D7077-0CC8-41E8-B75F-AC8E5B7F8327 Q37614595-2048EC0E-FF6B-4C44-97C8-C69C4A560F82 Q37785948-333CC8CC-6455-4AD4-ABBD-1D48AB171219 Q38056365-D5AD2379-14D9-42EB-8081-6CBE71970FA7 Q38177324-26F456F8-0C69-4494-99E7-6E6486E43849 Q38227889-31E213DB-4379-4A52-85EC-8E8306328071 Q38625948-009163BD-5845-4088-A08D-D30EA39803D3 Q39162824-6DBAE8B9-6B71-4B6D-B3BB-D7F245003EA6 Q39352977-DE41CEC5-3297-4086-9479-542902B64BB0 Q39478032-F54ED2DB-53CB-47DE-89A2-8F6662308E48 Q39535683-C3EE99AD-6D35-43F3-B1FF-E1F60E003D4B Q40798040-B7918CF4-A8B5-4853-BA62-FCD87A5EC456 Q41977894-EEEEFE73-032E-43DB-9D6B-47260A064260 Q42244370-A2FEDF0E-7086-4BF3-9364-2542D99214D3 Q44269708-1CF1EC0C-E5D0-45C3-B1DD-439E587C72AE Q50927490-1EF77F66-15FB-4A51-81B7-4B5E33A2BA1D Q51013344-4E98B59B-3898-41B8-9CFF-637B9DCC0237 Q54331671-0F627205-9857-4A9F-836A-A7E43015F294 Q55257705-2FB0BFEF-02F2-4B37-ADCE-92A6B1BF3926

P2860

Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma.

http://www.wikidata.org/entity/Q40275006

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Cytotoxic T cell responses to ...... with hepatocellular carcinoma.

@en

type

label

Cytotoxic T cell responses to ...... with hepatocellular carcinoma.

@en

prefLabel

Cytotoxic T cell responses to ...... with hepatocellular carcinoma.

@en

P1433

Q40275006-646ED2A1-E023-47F1-BFF9-030FFA7304A4

P1476

Q40275006-5F64E808-4292-4F2E-8878-02796904BEFA

P2093

Q40275006-1AB37BAA-DE76-48CF-BF40-B607D063F9E0

Q40275006-225AC19E-5F5A-4747-940E-54DA8FC4C452

Q40275006-22BEA321-F21B-4DE2-9B01-34BA9CA22D42

Q40275006-801C3EFA-4DF0-4140-898B-E828DEB005B9

Q40275006-B840CAA5-EDCA-462A-ABC1-86BEDF119086

Q40275006-BC44E004-9979-458C-B9CB-63306A1EE7D7

Q40275006-C910A49F-6D69-4B1E-A008-0BF8B3B879FE

Q40275006-E3574BE7-0947-4E19-8A83-4300DEFF365A

Q40275006-FD945772-1181-4B29-A72E-81FEB99E4BFA

P2860

Q40275006-6DE95035-0186-4038-A3F0-8B9072CDFFCF

Q40275006-7075F0ED-397F-444F-856A-FAA1DF63FDCA

P304

Q40275006-1C61B2A2-E13C-4E50-9352-F08640BB6A70

P31

Q40275006-2AFC155B-A86D-49A8-996D-BF429111393E

P356

Q40275006-0BD9BA62-978B-46BB-88A2-20A5F7FE2707

P407

Q40275006-D2339AC5-2E1B-4E14-9D53-6CD3F5FBB9BC

P433

Q40275006-726507BD-5996-4CDC-B1D7-9FD497DB58A6

P478

Q40275006-DAC82177-D36B-4703-B869-AC5863BC3A74

P577

Q40275006-CA3E2AB7-AF96-4CD0-AE43-26DCEA69CD9A

P5875

Q40275006-A9699970-BA73-4B89-BF31-82F27F40A722

P698

Q40275006-DC4C3D95-ACDE-4841-A178-AD968ADA2E1F

P921

Q40275006-C9B8ABEC-25EB-4AA4-B122-D7BC7FF4BB04

P356

P1433

P1476

Cytotoxic T cell responses to ...... with hepatocellular carcinoma.

@en

P2093

Eishiro Mizukoshi

http://www.w3.org/2001/XMLSchema#string

Hirokazu Tsuji

http://www.w3.org/2001/XMLSchema#string

Kiyotaka Kuzushima

http://www.w3.org/2001/XMLSchema#string

Kuniaki Arai

http://www.w3.org/2001/XMLSchema#string

Masafumi Takiguchi

http://www.w3.org/2001/XMLSchema#string

Shuichi Kaneko

http://www.w3.org/2001/XMLSchema#string

Tatsuya Yamashita

http://www.w3.org/2001/XMLSchema#string

Yasunari Nakamoto

http://www.w3.org/2001/XMLSchema#string

Yohei Marukawa

http://www.w3.org/2001/XMLSchema#string

P2860

T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein.

HER-2/neu and hTERT cryptic epitopes as novel targets for broad spectrum tumor immunotherapy.

P304

1284-1294

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.21203

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7053996

http://www.w3.org/2001/XMLSchema#string

P698

16729333

http://www.w3.org/2001/XMLSchema#string

P921